Skip to main content
Monica Gandhi, MD, Infectious Disease, San Francisco, CA

Monica Gandhi MD


Associate Professor, Medicine, UCSF School of Medicine

Join to View Full Profile
  • 995 Potrero Ave FL 6San Francisco, CA 94110

  • Phone+1 415-502-6285

  • Fax+1 415-476-8528

Dr. Gandhi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Infectious Disease, 2000 - 2002
  • University of California (San Francisco)/University of California School of Public Health
    University of California (San Francisco)/University of California School of Public HealthResidency, Public Health and General Preventive Medicine, 2000 - 2002
  • University of California (San Francisco)
    University of California (San Francisco)Residency, Internal Medicine, 1996 - 1999
  • Harvard Medical School
    Harvard Medical SchoolClass of 1996

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1998 - 2025
  • Infectious Disease
    American Board of Internal Medicine Infectious Disease

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Sex-Based Differences in HIV-1 Reservoir Activity and Residual Immune Activation  
    Marcelle Cedars, Monica Gandhi, Steven G Deeks, The Journal of Infectious Diseases

Press Mentions

  • Changes to COVID-19 Vaccine Guidelines: 4 Key Questions Answered
    Changes to COVID-19 Vaccine Guidelines: 4 Key Questions AnsweredMay 30th, 2025
  • CDC, FDA Limit Access to COVID Shots for Healthy Adults, Kids, and Pregnant People
    CDC, FDA Limit Access to COVID Shots for Healthy Adults, Kids, and Pregnant PeopleMay 29th, 2025
  • FDA Will Prioritize COVID Vaccine Approval for 65 and Older and High Risk
    FDA Will Prioritize COVID Vaccine Approval for 65 and Older and High RiskMay 20th, 2025
  • Join now to see all

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: